Cargando…

Hypercoagulability in Cushing Syndrome, Prevalence of Thrombotic Events: A Large, Single-Center, Retrospective Study

BACKGROUND: The risk of Cushing syndrome (CS) patients experiencing a thrombotic event (TE) is significantly higher (odds ratio; OR 18%) than that of the general population. However, there are currently no anticoagulation guidelines. METHODS: A retrospective, single-center, longitudinal study of pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suarez, Maria Gabriela, Stack, Madeleine, Hinojosa-Amaya, Jose Miguel, Mitchell, Michael D, Varlamov, Elena V, Yedinak, Chris G, Cetas, Justin S, Sheppard, Brett, Fleseriu, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009121/ https://www.ncbi.nlm.nih.gov/pubmed/32064411 http://dx.doi.org/10.1210/jendso/bvz033

Ejemplares similares

Medical Therapy with Pasireotide in Recurrent Cushing’s Disease: Experience of Patients Treated for At Least 1 Year at a Single Center
por: Yedinak, Chris G., et al.
Publicado: (2017)

MON-308 Pituitary Magnetic Resonance Imaging in the Postoperative Follow-Up of Patients with Acromegaly, Less Is More!
por: Fernandes, Stuti, et al.
Publicado: (2020)

Hypercortisolemia Recurrence in Cushing's Disease; a Diagnostic Challenge
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2019)

Monitoring Patient Improvement Parameters following Pasireotide Treatment in Cushing's Disease
por: Yedinak, Chris, et al.
Publicado: (2013)

Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis
por: Wagner, Jeffrey, et al.
Publicado: (2019)

Perioperative Management of a Patient With Cushing Disease
por: Varlamov, Elena V, et al.
Publicado: (2022)

Depression and Impulsivity Self-Assessment Tools to Identify Dopamine Agonist Side Effects in Patients With Pituitary Adenomas
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2020)

MON-277 Patient Health Questionnaire 9 (PHQ-9) and Barrat Impulsivity Scale (BIS-11); Tools to Identify Side Effects of Dopamine Agonist Treatment in Patients with Pituitary Adenomas
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2020)

Hypercoagulability in ACTH-Dependent Cushing Syndrome
por: Singh Sumal, Amit Kartar, et al.
Publicado: (2021)

Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how
por: Lopes, Valentim, et al.
Publicado: (2023)

Thrombotic and Hypercoagulability Complications of COVID-19: An Update
por: Shibeeb, Sapha, et al.
Publicado: (2021)

Hypercoagulability in Cushing’s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols
por: Feelders, Richard A., et al.
Publicado: (2022)

MON-320 Inter-Rater Reliability of T2 MRI Intensity of Somatotroph Adenomas; Endocrinologists vs. Neuroradiologist Pilot Study
por: Varlamov, Elena V, et al.
Publicado: (2020)

Recent advances in the medical treatment of Cushing’s disease
por: Fleseriu, Maria
Publicado: (2014)

Medical management of Cushing’s disease: what is the future?
por: Fleseriu, Maria, et al.
Publicado: (2012)

Pituitary-Directed Therapies for Cushing’s Disease
por: Langlois, Fabienne, et al.
Publicado: (2018)

Salivary Cortisol in the Diagnosis of Cushing Syndrome, Always More Than One!
por: Fleseriu, Maria
Publicado: (2020)

Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications
por: Haimei, MA
Publicado: (2020)

Update on medical treatment for Cushing’s disease
por: Cuevas-Ramos, Daniel, et al.
Publicado: (2016)

Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019
por: Wada, Hideo, et al.
Publicado: (2023)

MON-180 Risk for Hypercoagulability Among Patients with Cushing Syndrome. From the National Inpatient Sample
por: Ahmed, Fatima, et al.
Publicado: (2020)

New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
por: Fleseriu, Maria, et al.
Publicado: (2013)

THU033 High Prevalence Of Venous Thrombotic Events In Cushing’s Syndrome: Data From ERCUSYN
por: Isand, Kristina, et al.
Publicado: (2023)

Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies
por: Fleseriu, Maria, et al.
Publicado: (2016)

The Burden of Hypercoagulability in COVID-19
por: Kim, Madeleine, et al.
Publicado: (2022)

Treatment of Cushing’s syndrome with osilodrostat: practical applications of recent studies with case examples
por: Fleseriu, Maria, et al.
Publicado: (2022)

Prevalence of hypercoagulable states in stented thrombotic iliac vein compression syndrome with comparison of re-intervention and anticoagulation regimens
por: Cramer, Peyton, et al.
Publicado: (2021)

Case Report: Reversible cabergoline-associated cardiac valvulopathy post drug discontinuation
por: Yedinak, Chris G., et al.
Publicado: (2014)

Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise
por: Skeith, Leslie, et al.
Publicado: (2022)

Response to Letter to the Editor From Asa and Mete: “Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease”
por: Langlois, Fabienne, et al.
Publicado: (2022)

Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease
por: Langlois, Fabienne, et al.
Publicado: (2021)

Functioning Pituitary Adenomas – Current Treatment Options and Emerging Medical Therapies
por: Varlamov, Elena V, et al.
Publicado: (2019)

Glucocorticoid Receptor Antagonism as a New “Remedy” for Insulin Resistance—Not There Yet!
por: Varlamov, Elena V, et al.
Publicado: (2021)

Hypercoagulability in Dogs with Blastomycosis
por: McMichael, M.A., et al.
Publicado: (2015)

The Hypercoagulable Profile of Organ Donors with Intravascular Clots Has a Similar Profile to COVID-19 and ICU Patients with Thrombotic Complications
por: Moore, Hunter B., et al.
Publicado: (2021)

Clinical features and complications of acromegaly at diagnosis are not all the same: data from two large referral centers
por: Varlamov, Elena V, et al.
Publicado: (2021)

Familial Mediterranean Fever and Hypercoagulability
por: Tayer-Shifman, Oshrat E., et al.
Publicado: (2011)

Dipyrimadole & Post-Operative Hypercoagulability
por: Jayaswal, U.
Publicado: (1967)

Chronometric vs. Structural Hypercoagulability
por: Delianu, Carmen, et al.
Publicado: (2020)

Hypercoagulation in COPD: the clot thickens
por: Rahaghi, Farbod N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3bgtfjnn238525bejivqkp0t3d